Dulaglutide vs Nivolumab

Dulaglutide vs Nivolumab: Overview

This comparison examines the pharmacological differences between Dulaglutide and Nivolumab.

Mechanism of Action

Dulaglutide: GLP-1 receptor agonist fused to Fc fragment; enhances glucose-dependent insulin secretion.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Dulaglutide — 5 days; Nivolumab — 27 days.

Chemical Properties

Type: Dulaglutide — Protein; Nivolumab — Antibody.